Søren Laurberg

Søren Laurberg

Auto-generated profile, based on publicly available information

Søren Laurberg

Aarhus University Hospital

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2014 in Current Colorectal Cancer Reports
Verified
Journal Article
Open access
PDF file
TCTina Yen-Ting Chen
Tina Yen-Ting Chen
KEKatrine J. Emmertsen
Katrine J. Emmertsen
SLSøren Laurberg
Søren Laurberg
With enhanced surgical techniques and neoadjuvant therapy in rectal cancer, survivorship issues are at the forefront of clinical practice and research. More and more patients are living with altered bowel habits following rectal cancer surgery. Sound assessment of anorectal function after rectal cancer surgery is the foundation for the continuing effort to explore the adverse effects of such surgery on bowel function, as well as for working towards reducing these effects. The quality of the assessment is predominantly determined by the instrument administered. This article reviews various questionnaires for capturing anorectal function after surgery in rectal cancer, discussing their attributes and suitability for different evaluation contexts.

7 January 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MNMette Nielsen
Mette Nielsen
PRPeter Rasmussen
Peter Rasmussen
BPBodil Ginnerup Pedersen
Bodil Ginnerup Pedersen
RHRikke Hagemann-Madsen
Rikke Hagemann-Madsen
JLJacob Lindegaard
Jacob Lindegaard
SLSøren Laurberg
Søren Laurberg

1 November 2014 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
DMD.L.E. Munkedal
D.L.E. Munkedal
NWNicholas P West
Nicholas P West
LILene Hjerrild Iversen
Lene Hjerrild Iversen
RHR. Hagemann-Madsen
R. Hagemann-Madsen
PQP. Quirke
P. Quirke
SLS. Laurberg
S. Laurberg


1 January 2012 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
HTHenriette V Thaysen
Henriette V Thaysen
PJP Jess
P Jess
SLSøren Laurberg
Søren Laurberg
MGM Groenvold
M Groenvold
The European Organisation for Research and Treatment of Cancer (EORTC) quality of life colorectal questionnaire module (QLQ-CR38) was developed in 1999, and an update, the QLQ CR29 was published recently. To date the Danish version of the questionnaire has not been validated. The aim of this study was to examine the psychometric properties of the Danish version of EORTC QLQ-CR38.

Verified
Journal Article
Open access
PDF file
MBMette Borre
Mette Borre
JFJanne Fassov
Janne Fassov
JPJakob Lykke Poulsen
Jakob Lykke Poulsen
PCPeter Christensen
Peter Christensen
SLSøren Laurberg
Søren Laurberg
KKKlaus Krogh
Klaus Krogh
Gastrointestinal (GI) symptoms are common in patients receiving radiotherapy, chemotherapy, and/or surgery for cancer in the pelvic organs. The aim of the present prospective cohort study was to report the efficacy of dietary intervention in patients with chronic GI sequelae to treatment of cancer in pelvic organs and insufficient symptomatic effect of medical treatment. Eighty-eight patients were offered specialist dietitian guidance. Gastrointestinal symptoms and quality of life were assessed before and after intervention by validated questionnaires. The main dietary interventions were low-fat diet (n = 44; 50%), modification of dietary fiber content (n = 19; 33%), dietary restrictions with a low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet (n = 18; 20%), gluten-free diet (n = 1; 1%), and other dietary advice (n = 6; 7%). Compared to baseline, dietary intervention improved quality of life (EQ5D scale) (p < 0.01), bowel function for the last four weeks (p < 0.02), stool frequency (p < 0.03), constipation (p < 0.05), incomplete rectal emptying at defecation (p < 0.02), and performing usual activities (p < 0.0). In conclusion, this observational study using tailored dietary intervention showed that symptoms can be reduced and quality of life can be improved in patients with chronic GI sequelae following treatment of cancer in the pelvic organs not responding sufficiently to medical treatment.